Literature DB >> 2324609

Oxidative stress and abnormal cholesterol metabolism in patients with adult respiratory distress syndrome.

C E Cross1, T Forte, R Stocker, S Louie, Y Yamamoto, B N Ames, B Frei.   

Abstract

Oxidative stress has been implicated in the adult respiratory distress syndrome (ARDS). In this study, we determined the levels of selected antioxidants in the plasma of 25 patients with ongoing ARDS and 16 healthy control subjects. We also examined these plasmas and pulmonary edema fluid of ARDS patients for lipid hydroperoxides. Both ascorbate and ubiquinol-10 concentrations in ARDS plasma were significantly lower than in normal plasma. alpha-Tocopherol concentrations, when standardized to total plasma cholesterol, were not lower in ARDS patients than in normal subjects. A pattern of antioxidant levels virtually identical to that observed in ARDS plasma was obtained after in vitro incubation of healthy plasma with stimulated polymorphonuclear leukocytes: very low ascorbate, decreased ubiquinol-10, and unchanged alpha-tocopherol concentrations. Nanomolar concentrations of lipid hydroperoxides were found in pulmonary edema fluid of ARDS patients, but not in plasma, nor in the plasma of healthy individuals, when a sensitive and selective chemiluminescence assay for hydroperoxides was used. ARDS patients also showed significant decreases in plasma levels of cholesterol esters in conjunction with discoidal high-density lipoprotein profiles, indicating a decrease in lecithin-cholesterol acyltransferase activity. We conclude that ARDS is associated with oxidative stress, possibly exerted by oxidants released from activated phagocytic leukocytes, and major changes in plasma cholesterol metabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324609

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  20 in total

1.  Auricularia auricular-judae polysaccharide attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress and inflammation.

Authors:  L I Zhuan-Yun; Yao Xue-Ping; Liu Bin; Ha Nizaier Reheman; Gao Yang; Sun Zhan; M A Qi
Journal:  Biomed Rep       Date:  2015-05-26

Review 2.  Review of progress in sterol oxidations: 1987-1995.

Authors:  L L Smith
Journal:  Lipids       Date:  1996-05       Impact factor: 1.880

3.  Tanshinone II is a potent candidate for treatment of lipopolysaccharide-induced acute lung injury in rat model.

Authors:  Ling Li; Yong-Gang Zhang; Yu-Fei Tan; Jing-Jing Zhao; Hua-Ru Zhang; Bing Zhao
Journal:  Oncol Lett       Date:  2017-12-11       Impact factor: 2.967

4.  Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.

Authors:  R Stocker; V W Bowry; B Frei
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

5.  Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

Authors:  B Frei; M C Kim; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

6.  Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.

Authors:  D Kietzmann; R Kahl; M Müller; H Burchardi; D Kettler
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Characteristics of neutrophil influx in rat lungs following fecal peritonitis.

Authors:  J G Peralta; M L Barnard; J F Turrens
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

8.  Human blood cells support the reduction of low-density-lipoprotein-associated cholesteryl ester hydroperoxides by albumin-bound ebselen.

Authors:  J Christison; H Sies; R Stocker
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

9.  Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid.

Authors:  B Frei; T M Forte; B N Ames; C E Cross
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

10.  Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Horst Fischer; Christian Schwarzer; Beate Illek
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.